Targeting Biofilms Therapy: Current Research Strategies and Development Hurdles
Round 1
Reviewer 1 Report
The scientific data is compiled well but the presentation could be a lot better. The flow of the text and the choice of words is not very good and the manuscript will be hugely benefitted by having it edited by a professional language editor.
Author Response
Please see the attachment.
Author Response File: Author Response.docx
Reviewer 2 Report
- Line 10 and whenever appropriate: Biofilm is not a virulence factor. Many publications use this incorrect statement. It is a growth state of microorganisms. Please revise it. Production of virulence factors varies in planktonic versus biofilm bacteria.
- Line 20: Avoid unnecessary upper-case letter and delete I from QSI.
- 1: The text in the diagram is not clear. The quality should be improved. Additionally, it will be better if cartoon is drawn with bacterial cells.
- Lines 134 and 135: Please specify what type of coli?
- Line 149: Delete ing from targeting
- Many places (e.g., lines 175-178) the genus and species are not italicized.
- Table 2: any specific example of cysteine proteases secreted by mesenchymal stromal cells?
- Line 452 (Targeting dormant cells in biofilms): DNA cross-linking drugs like cisplatin (Biotechnol Bioeng 2016,113:1984-1992) and mitomycin C (Environ Microbiol 2015, 17:4406-4414) have been proved to eradicate biofilm/dormant cells. So, it is important to include a brief section on this citing these papers.
Author Response
Please see the attachment.
Author Response File: Author Response.docx